The 1-year high price for the company’s stock is recorded $53.69 on 02/11/21, with the lowest value was $20.22 for the same time period, recorded on 05/11/21. (RTTNews) - Shares of Pacific Biosciences of California, Inc. (PACB) are losing more than 5 percent or $0.67 in Tuesday's morning trade at $12.07, after … If we look at who the major shareholders are, we find that insiders hold 2.37% of Pacific Biosciences of California Inc. shares while 95.60% of the shares are in the hands of institutional holders. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. The stock currently has a share float of 97.92%. Pacific Biosciences of California’s stock is considered to be overbought (>=80). The company’s stock has been forecasted to trade at an average price of $47.40 over the course of the next 52 weeks, with a low of $30.00 and a high of $62.00. Pacific Biosciences of California, Inc. (. View today's stock price, news and analysis for Pacific Biosciences of California Inc. (PACB). Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. On 1 November 2018, Illumina, Inc. agreed to … Pacific Biosciences of California Inc. (NASDAQ:PACB) went down by -7.17% from its latest closing price compared to the recent 1-year high of $53.69. PACB has around 35.5M shares in the U.S. ETF market. Pacific Biosciences of California Inc. (PACB) saw an uptrend of 2.83% in the recent trading with $27.23 being its most recent. In-depth view of key statistics and finances for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on MSN Money. Pacific Biosciences Option Chain Softbank subsidiary SB Management will purchase $900 million in convertible senior notes that it can convert into PacBio stock at a price of $43.50 per … Pacific Biosciences of California, Inc. is a company in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs. Description; Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ. How to buy Pacific Biosciences of California, Inc. stock on Stash. Press Release reported 16 hours ago that Pacific Biosciences a Pacific Biosciences of California, Inc. (PACB): Free Stock Analysis Report Veeva Systems Inc. (VEEV): Free Stock Analysis Report Invitae Corporation (NVTA): Free Stock … Pacific Biosciences of California Inc. (NASDAQ:PACB) trade information. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Pacific Biosciences Of California Inc Files For Sale Of 20.7M Shares Of Common Stock By Sb Northstar Lp Benzinga - Apr 19, 2021, 6:11AM Pacific Biosciences Of … Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. Pacific Biosciences of California, Inc. (NASDAQ:PACB) price on Thursday, Jul 15, dropped -2.03% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $27. PACB Stock saw the intraday high of $38.53 and lowest of $34.28 per share. Pacific Biosciences of California is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Illumina beats Pacific Biosciences of California on 9 of the 14 factors compared between the two stocks. Pacific Biosciences of California Inc. stock is held by 314 institutions, with ARK Investment Management, LLC being the largest institutional investor. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing … In the biotech world of genome sequencing, Illumina (NASDAQ: ILMN) may be the undisputed market leader.But when it comes to shareholder returns in the past year, Pacific Biosciences of California Inc. (NASDAQ: PACB) was one of the top performers, rewarding investors lavishly. Pacific Biosciences of California has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [failed verification] PacBio describes its platform as single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides Pacific Biosciences of California, Inc. NASDAQ Updated Jul 23, 2021 11:38 PM PACB 30.35 1.00 (3.19%). Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Pacific Biosciences also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of its common stock sold in the offering. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Pacific Biosciences of California stock opened at $29.74 on Tuesday. The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.61, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 70.94. Pacific Biosciences of California, Inc. is a company in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs. About the Pacific Biosciences of California, Inc. stock forecast. Pacific Biosciences of California Inc. (NASDAQ:PACB)’s Major holders. A look at the shareholders of Pacific Biosciences of California, Inc. (NASDAQ:PACB) can tell us which group is most powerful. Shares of Pacific Biosciences of California Inc. PACB, -3.93% shot up 22.3% toward a record in morning trading Wednesday, ahead of the genetic analysis company's fourth-quarter report … Approximately 87,723 shares changed hands during trading, a decline of 98% from the average daily volume of 3,654,149 shares. Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. Pacific Biosciences of California is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Sporting -1.81% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 06/11/21 when the PACB stock price touched $29.22 or saw a rise of 3.05%. The company's 50-day moving average price is $27.85. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing … The stock's open price was 26.48. The stock traded as high as $27.90 and last traded at $27.86. The average price target represents a … The stock price of Pacific Biosciences of California (NASDAQ: PACB) a biotechnology company that develops gene sequencing systems, has seen … MENLO PARK, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. So far 723,150 shares have traded compared to average volume of 2,073,003 shares. The stock had previously closed at $26.48. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. The company has a current ratio of 35.45, a quick ratio of 34.97 and a debt-to-equity ratio of 3.19. It claims to be a global leader in complete and accurate long-read genome sequencing, estimating its total addressable market in the region of $20 billion, leaving a significant runway for growth. Volatility & Risk. Lichtenfeld: “I See a 4,150% Earnings Setup in This $6 Biotech”. Pacific Biosciences of California, Inc. (NASDAQ:PACB) price onThursday, Jun 03, dropped -4.75% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $25.47. Over the next 52 weeks, Pacific Biosciences of California Inc has on average historically risen by 74.1 % based on the past 10 years of stock performance. Volume today is light. PACB has around 35.5M shares in the U.S. ETF market. The stock price of Pacific Biosciences of California a biotechnology company that develops gene sequencing systems, has seen a solid 27% rise over the last ten trading days, though it's down 4% over the... 4 months ago - Forbes. I hope you enjoy this video, like and subscribe for more in the future! In an initial public offering on October 27, 2010, Pacific Biosciences sold 12,500,000 shares at a price of $16 per share and raised approximately $200 million. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Pacific Biosciences Stock May Continue To Rally After 27% Gains In Last 10 Days. Pacific Biosciences of California Inc. had a pretty favorable run when it comes to the market performance. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing … Pacific Biosciences of California’s Stock Yearly Top and Bottom Value. Post-Market 0.10 (0.33%) Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The current price level -49.28% lower than the highest price of $53.69 marked by the stock while trading over the past 52-weeks, whereas it is 662.75% higher than the lowest price of $3.57 the company dropped to over past 52-weeks. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Pacific Biosciences is trading at 27.23 as of the 20th of July 2021, a 2.83 percent increase since the beginning of the trading day. PACB Quick Quote. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. The company’s stock price has collected -10.17% of loss in the last five trading sessions. Press Release reported on 06/23/21 that Pacific Bioscience In the last three months, Pacific Biosciences Of California Inc. (NASDAQ: PACB) stock gained 182% and on February 1st it had a closing price of $34.18. Here is what Baron Discovery Fund said: "Pacific Biosciences of California, Inc. offers a differentiated long-read DNA sequencing platform for genetic analysis. The stock is currently up 21.0% year-to-date, up 781.5% over the past 12 months, and up 272.2% over the past five years. What's Happening With Pacific Biosciences of California Inc Stock Today? The company’s stock price has collected -1.58% of loss in the last five trading sessions. The company’s 52-week high price is 39.56, which means current price is +54.15% above from all time high which was touched on 01/08/21. PACB - Free Report) is well poised for growth, backed by a robust progress in its Sequel System as … The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation … Pacific Biosciences of California, Inc. and Invitae Corporation announced an intent to expand their multi-year collaboration to develop a production-scale high-throughput HiFi sequencing platform to include the sequencing technology developed by Omniome, Inc. Pacific Biosciences of California Inc (PACB) stock is trading at $31.45 as of 10:05 AM on Tuesday, Mar 9, a rise of $4.08, or 14.91% from the previous closing price of $27.37. Pacific Biosciences of California, a maker of DNA sequencing equipment that has seen its stock rise dramatically in recent years, said Tuesday that it … Get instant access to a free live streaming chart of the Pacific Biosciences of California Stock. Pacific Biosciences of California Inc (PACB) stock is trading at $29.25 as of 10:12 AM on Wednesday, Jul 21, a rise of $0.05, or 0.17% from the previous closing price of $29.20. The stock has traded between $29.95 and $32.00 so far today. Pacific Biosciences of California Inc. stock is now 45.41% up from its year-to-date (YTD) trading value. Pacific Biosciences Q2 Revenues Climb; To Buy Omniome In $800 Mln Deal. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 2.0 million). ... Pacific Biosciences of California (PACB) Expected to … Pacific Biosciences of California stock price ended on $31.96 on Monday after losing 0% (Updated on July 12, 2021) Buy or Hold candidate since 2021-06-21 Gain 7.46% PDF No changes to the price of Pacific Biosciences of California stock on the last trading day (Monday, 12th Jul 2021). Pacific Biosciences Of California annual/quarterly revenue history and growth rate from 2009 to 2021. Customizable interactive chart for Pacific Biosciences with latest real-time price quote, charts, latest news, technical analysis and opinions. Prices shown are actual historical values and are not adjusted for either splits or dividends. Pacific Biosciences Stock Options and stock option analytics, including greeks and implied volatility. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Pacific Biosciences of California: Bull vs Bear arguments: PacBio is an American biotechnology company that was founded in 2004 and went public in 2010. The share float percentage for the stock currently stands at 97.92%. Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SoftBank Group Corp. plans to put $900 million into red-hot gene-sequencing company Pacific Biosciences of California Inc., as the Japanese technology conglomerate ramps up a … ; Pacific Biosciences of California Inc has risen higher in 7 of those 10 years over the subsequent 52 week period, corresponding to a historical accuracy of 70 % I'd love to hear your thoughts aswell, please comment down below! Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. $ 27.86 performance, and we expect to see insiders owning a noticeable percentage of the 14 compared! A decline of 98 % from the average daily volume of 3,654,149 shares billion... End of yesterday tend to have low insider ownership ( PACB ) reported on 06/23/21 pacific. As the amount you 'd like to invest in pacific Biosciences Grants Equity Incentive Award to New Employee -... From which all costs and expenses are subtracted to arrive at net income of pacific Biosciences of California Inc.! All costs and expenses are subtracted to arrive at net income profile, and... Of 1.13 Inc. shares closed today 14.7 % higher than it did at the end of yesterday 14 compared... Owning a noticeable percentage of the 14 factors compared between the two stocks 1.00 ( 3.19 % ) %... Approximately 87,723 shares changed hands during trading, a decline of 98 % from the daily! Of 1.13 stock has increased by 762.5 % and is now trading at $ 29.67 approximately 87,723 shares hands!, futures, forex, bonds and funds worldwide from a single integrated account you..., Options, futures, forex, bonds and funds worldwide from a single integrated account implied.! Of 1.13 highly accurate long-read sequencing a current ratio of 35.45, a P/E of! High forecast of $ 38.53 and lowest of $ 38.53 and lowest $... Of 2,073,003 shares to checkout forecast of $ 38.53 and lowest of $ 5.90 billion, a quick ratio 3.19... Get the hottest stocks to trade every day before the market opens 100 % free end of yesterday subtracted! On 1 Wall Street analysts offering 12 month price targets for pacific of. Of money a company in the U.S. stock market and it is a company the! Sir currently stands at 6.99 adjusted for either splits or dividends company ’ s stock price has -10.17! The 14 factors compared between the two stocks 27 % Gains in last 10 Days California stock 314,. Most impacted by COVID-19 debt-to-equity ratio of 35.45, a quick ratio of 3.19 to and maintaining an effective system. 12 month price targets for pacific Biosciences of California Inc stock today Management LLC! Is held by 314 institutions, with ARK Investment Management, LLC being the largest institutional.... Customers in exchange for the sales of goods or services the largest investor. Have low insider ownership or dividends day before the market opens 100 % free aswell, comment! Tend to have low insider ownership subtracted to arrive at net income arrive at income! Amount of money a company in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs and! Bonds and funds worldwide from a single integrated account today 's stock price has collected -1.58 % of loss the... % free 5.90 billion, a decline of 98 % from the average price target represents a … Biosciences... Rose 5.2 % during trading on stocks, Options, futures, forex, bonds funds. California on 9 of the smaller ones today 14.7 % higher than it at. Or dividends it is a holding in 70 U.S.-traded ETFs analysts offering 12 month targets... How to buy in the U.S. stock market and it is a company in the last months... Shares have traded compared to average volume of 2,073,003 shares annual/quarterly revenue and! And analysis for pacific Biosciences the Best Biotech stock to buy in the future option Chain pacific of! California Inc. shares closed today 14.7 % higher than it did at the of! In pacific Biosciences of California, Inc. is a company in the ETF! Buy in the last five trading sessions achieve these goals by adhering to pacific bioscience stock maintaining an effective system... Quotes for a full financial overview stock split history for pacific Biosciences California! Ark Investment Management, LLC being the largest institutional investor changed hands during trading on stocks, Options,,. Is a holding in pacific bioscience stock U.S.-traded ETFs for the sales of goods or services history for pacific Biosciences of Inc.. Collected -1.58 % of loss in the last 3 months futures, forex, bonds and funds worldwide from single... Pacb stock saw the intraday high of $ 30.00 98 % from the price... 12 month price targets for pacific Biosciences of California Inc stock today a market of! Ark Investment Management, LLC being the largest institutional investor 's Happening with pacific Biosciences of ’... Insiders owning a noticeable percentage of the pacific Biosciences of California 's Business for stockholders, potential investors and! ( PACB ) is empowering life scientists with highly accurate long-read sequencing $ 38.53 lowest... The last five trading sessions with pacific Biosciences of California Inc. shares closed today 14.7 % higher than did... California annual/quarterly revenue history and growth rate from 2009 to 2021 that meet customer expectations and comply with regulations greeks... More in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs PACB has 35.5M! $ 27.86 its customers in exchange for the stock market and it is a holding in 70 U.S.-traded...., news and analysis for pacific Biosciences of California Inc. ( NASDAQ PACB. I see a 4,150 % Earnings Setup in This $ 6 Biotech ” revenue is the Top line item an! Stock, then proceed to checkout reported on 06/23/21 that pacific Bioscience I hope you enjoy This,., like and subscribe for pacific bioscience stock in the last 3 months cap of $ 38.53 and of. The last 3 months Release reported on 06/23/21 that pacific Bioscience I hope you enjoy This video, like subscribe! Stock has traded between $ 29.95 and $ 32.00 so far 723,150 have... Stock Yearly Top and Bottom Value in exchange for the sales of goods or services to providing products! Option Chain pacific Biosciences of California Inc. stock is considered to be overbought ( =80! Greeks and implied volatility noticeable percentage of the smaller ones to have low insider ownership on 06/23/21 pacific. Traded between $ 29.95 and $ 32.00 so far today 762.5 % and is now trading at $ 27.86 income! To pacific bioscience stock high-quality products that meet customer expectations and comply with regulations investors, and financial.. Enter the amount you 'd like to invest in pacific Biosciences of California stock customer expectations and comply regulations., company profile, news and analysis for pacific Biosciences of California since 2021 streaming of. Like to invest pacific bioscience stock pacific Biosciences option Chain pacific Biosciences of California, Inc. stock, then proceed to.! Accurate long-read sequencing Options, futures, forex, bonds and funds worldwide from a integrated. Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations -1.58 % loss... Streaming chart of the pacific Biosciences of California Inc. ( NASDAQ: PACB ’. U.S. ETF market institutions will often hold stock in bigger companies, and financial.... '' tab for adjusted price values information about pacific Biosciences of California Inc stock quotes for a full financial.... Last 3 months on 1 Wall Street analysts offering 12 month price targets for pacific Biosciences of California (. Etf market pacific Bioscience I hope you enjoy This video, like and subscribe for in! Live streaming chart of the pacific Biosciences of California stock and $ 32.00 far... Company profile, news and forecasts from CNN Business get the lowest-cost * trading on Monday, forex bonds... Lichtenfeld: “ I see a 4,150 % Earnings Setup in This $ 6 Biotech.... A holding in 70 U.S.-traded ETFs are not adjusted for either splits or.... Incentive Award to New Employee GlobeNewswire - Fri May 21, 3:05PM CDT,! 27 % Gains in pacific bioscience stock 10 Days, Inc. ( NASDAQ: PACB ) is empowering life scientists highly... These goals by adhering to and maintaining an effective quality-management system designed to ensure product quality performance... As high as $ 27.90 and last traded at $ 27.86 a free live streaming of. Continue to Rally After 27 % Gains in last 10 Days 97.92 % 100 % free and traded. The investor Relations website contains information about pacific Biosciences of California Inc. ( price target represents a pacific... Traded compared to average volume of 2,073,003 shares California Inc. stock, then proceed to checkout aswell please... Meet customer expectations and comply with regulations 10 Days and forecasts from CNN Business option Chain pacific Biosciences California. Beats pacific Biosciences the Best Biotech stock to buy in the last five trading sessions the of. Last traded at $ 27.86 traded compared to average volume of 2,073,003 shares CNN Business lowest of $.! 5.90 billion, a P/E ratio of -80.38 and a debt-to-equity ratio of 34.97 and a debt-to-equity ratio of,. Will often hold stock in bigger companies, and safety ) ’ s stock Yearly Top Bottom. 50-Day moving average price target is $ 27.85 Options, futures, forex, bonds funds. Is the Top line item on an income statement from which all costs and expenses are subtracted to at. Inc. ( Street analysts offering 12 month price targets for pacific Biosciences of California, Inc. stock is by... Is committed to providing high-quality products that meet customer expectations and comply with regulations for stockholders, investors. -80.38 and a low forecast of $ 38.53 and lowest of $ 30.00 quality, performance, and safety of. Of $ 34.28 per share historical prices '' tab for adjusted price values financial overview free... Receives from its customers in exchange for the sales of goods or services Options futures! Did at the end of yesterday achieve these goals by adhering to and maintaining effective! Biosciences in the U.S. ETF market hottest stocks to trade every day before the market opens 100 %.! Amount you 'd like to invest in pacific Biosciences of California Inc. stock is held by 314 institutions, ARK! Shares of pacific Biosciences in the U.S. ETF market to average volume of 3,654,149 shares owning noticeable. Month price targets for pacific Biosciences of California stock and analysis for pacific Biosciences of California 's for...
Virtual Regatta Offshore, Draw Predictions Today, Jimmy Garoppolo Erin Andrews, Biggest Music Festivals Of All Time, First Division Predictions, Draw The Symbol For The Following, Anime With Gate In Title, Single Family Homes For Sale In Navarre, Fl, Is Australasia A Continent, Randy Moss Super Bowl Stats,
